MARIO B PEREIRA

Allopathic & Osteopathic Physicians|Internal Medicine PLANTATION, FL NPI 1760680466

General Payments — all program years on this page

$2,669.29

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 137
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $294.04 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $294.0415

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $74.394
GlaxoSmithKline, LLC. $62.813
Novo Nordisk AS $40.362
Acerta Pharma LLC $29.312
Astellas Pharma US Inc $26.891
ABBVIE INC. $24.031
E.R. Squibb & Sons, L.L.C. $21.051
PFIZER INC. $15.201

By program year

Program yearAmountRecords
2018 $494.0230
2019 $465.8229
2020 $169.1610
2021 $497.1515
2022 $341.1618
2023 $407.9420
2024 $294.0415

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096895197 Novo Nordisk Inc $23.31 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097060762 Novo Nordisk Inc $17.05 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101365294 E.R. Squibb & Sons, L.L.C. $21.05 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104519366 AstraZeneca Pharmaceuticals LP $13.26 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105236059 ABBVIE INC. $24.03 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105255282 AstraZeneca Pharmaceuticals LP $16.05 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111674684 Amgen Inc. $17.68 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116064143 GlaxoSmithKline, LLC. $24.67 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116207493 GlaxoSmithKline, LLC. $16.38 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116683691 GlaxoSmithKline, LLC. $21.76 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117351239 Amgen Inc. $20.17 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117351241 Amgen Inc. $18.20 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117351243 Amgen Inc. $18.34 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130942038 PFIZER INC. $15.20 04/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139321388 Astellas Pharma US Inc $26.89 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.